nitric oxide synthase inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namenitric oxide synthase inhibitors (Pfizer)
Drug Alias NameCP-536404CP-695516CP-601073
ClassificationSmall molecules
Mechanisms of ActionNitric oxide synthesis inhibitorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsPainStrokeParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsPainStrokeParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A